5341.KLSE LACMED

Healthcare Medical Devices Kuala Lumpur Exchange
0.6750 MYR
Close of Oct 29, 2026
Market cap
MYR 266M
P/E
13.5x
P/B
2.24x
ROE
10.3%
Dividend yield
1.88%
Fundamental score
2.7/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 5341.KLSE undervalued?

Graham number
Price0.6750
Graham value0.5826
Premium15.9%

5341.KLSE trades 15.9% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

LACMED fundamental analysis

13 of 22 checks passed

ROE 1/2

Moderate return on equity (10.3%), between 10% and 20%.

ROA 1/1

Return on assets (5.5%) is above the industry median (-7.4%).

Profit Consistency 1/2

Profitable for 4 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share history is shorter than 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 1/1

Last year's EPS growth (7.5%) is above the industry median (5.2%).

Revenue Growth 2/2

Revenue grew 23.7% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (0.8%), 40% or less.

Debt Trend 0/1

Debt to equity history is shorter than 5 years.

Debt Coverage 0/1

Operating cash flow does not cover 20% of total debt.

Interest Coverage 1/1

EBIT is 20.0x against interest expense, well covered.

PE vs Market 0/1

PE (13.3x) is above the market median (11.4x).

PE vs Industry 1/1

PE (13.3x) is below the industry median (19.0x).

PBV 1/1

Price to book (2.2x) is below the industry median (2.5x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 29.3, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 1/2

Dividend yield (1.9%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 1/1

Payout ratio is 22.8%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

About LACMED

LAC Med Berhad engages in the distribution, supply, and integration of medical devices, diagnostic equipment, and digital health solutions for diagnostic purposes in Malaysia and Indonesia. The company offers diagnostic equipment, radiographic, ultrasound, magnetic resonance imaging (MRI), as well as software systems and maintenance services. It serves hospitals, clinics, and healthcare providers. The company was incorporated in 2003 and is headquartered in Petaling Jaya, Ma…

Full company profile